When Device42 is easier to justify
Device42 is easier to justify when the team wants cloud / on-prem, custom quote, Web, and a more vendor-led validation path. It becomes more credible when those conditions match the real environment instead of the idealized one from the demo process.
Device42 should stay on the shortlist if it creates less commercial ambiguity than GLPI and gives the team a cleaner path through rollout, policy design, and day-two administration. This matters most when the organization is trying to avoid hidden work after implementation.
The risk with Device42 is assuming that product familiarity or feature breadth alone should carry the decision. Buyers still need to confirm what changes after the first phase, how much tuning remains, and whether the platform continues to fit once procurement assumptions become operational reality.
When GLPI is easier to justify
GLPI is easier to justify when the team wants cloud / on-prem, open source, Web, and a visible trial path. It becomes more credible when those conditions match the real environment instead of the idealized one from the demo process.
GLPI should stay on the shortlist if it creates less commercial ambiguity than Device42 and gives the team a cleaner path through rollout, policy design, and day-two administration. This matters most when the organization is trying to avoid hidden work after implementation.
The risk with GLPI is assuming that product familiarity or feature breadth alone should carry the decision. Buyers still need to confirm what changes after the first phase, how much tuning remains, and whether the platform continues to fit once procurement assumptions become operational reality.